Ryan P J, Blake G M, Fogelman I
Department of Nuclear Medicine, Guy's Hospital, London, United Kingdom.
Ann Rheum Dis. 1992 Sep;51(9):1063-5. doi: 10.1136/ard.51.9.1063.
The bone mineral densities of the lumbar spine and femoral neck were determined by dual energy chi ray absorptiometry in 110 women aged 40-82 years (average 65 years) with spinal osteoporosis who had had at least one atraumatic vertebral compression fracture and in 1026 normal women aged 40-79 years (average 52 years). The women with osteoporosis showed a significant decrease in bone mineral density (BMD) at the lumbar spine and femoral neck compared with age matched normal women (sixth decade of life -26% spine, -23% femoral neck; seventh decade -26% spine, -16% femoral neck). The fracture threshold, defined as the 90th centile of spinal BMD for women with osteoporosis, was 0.81 g/cm2 at the lumbar spine and 0.656 g/cm2 at the femoral neck. Five per cent of normal women aged 40-49 years, 20% aged 50-59 years, and 45% aged 60-69 years had a BMD below this threshold. To maintain the bones of women above the fracture threshold until the age of 70 years about 50% of postmenopausal women need hormone replacement therapy. However, if the BMD is to be kept above the fracture threshold for a women's lifetime, e.g. until the age of 80-90 years, then most women will need treatment, though for various lengths of time depending on their initial BMD. Measurements of BMD in postmenopausal women currently help in identifying the risk of osteoporotic fractures but in the lifetime assessment of risk in a single subject they may have a more important role in deciding the duration of hormone replacement therapy.
采用双能X线吸收法测定了110例年龄在40 - 82岁(平均65岁)、患有脊柱骨质疏松症且至少发生过一次非创伤性椎体压缩骨折的女性以及1026例年龄在40 - 79岁(平均52岁)的正常女性的腰椎和股骨颈骨密度。与年龄匹配的正常女性相比,患有骨质疏松症的女性腰椎和股骨颈的骨密度显著降低(60岁年龄段 - 腰椎26%,股骨颈23%;70岁年龄段 - 腰椎26%,股骨颈16%)。骨折阈值定义为骨质疏松症女性脊柱骨密度的第90百分位数,腰椎为0.81 g/cm²,股骨颈为0.656 g/cm²。40 - 49岁的正常女性中有5%、50 - 59岁的有20%、60 - 69岁的有45%骨密度低于此阈值。为使女性骨骼保持在骨折阈值以上直至70岁,约50%的绝经后女性需要激素替代疗法。然而,如果要使女性一生的骨密度都保持在骨折阈值以上,例如直至80 - 90岁,那么大多数女性都需要治疗,不过治疗时间长短取决于她们的初始骨密度。目前对绝经后女性骨密度的测量有助于识别骨质疏松性骨折的风险,但在对单个个体的终生风险评估中,它们在决定激素替代疗法的持续时间方面可能发挥更重要的作用。